Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Nov;70(5):950–953. doi: 10.1038/bjc.1994.427

A case-control study of diabetes mellitus and cancer risk.

C La Vecchia 1, E Negri 1, S Franceschi 1, B D'Avanzo 1, P Boyle 1
PMCID: PMC2033532  PMID: 7947103

Abstract

The relationship between diabetes mellitus and cancer risk was investigated using data from an integrated series of case-control studies conducted in Northern Italy between 1983 and 1992. Cases were 9,991 patients with incident, histologically confirmed neoplasms below age 75, including 181 cancers of the oral cavity and pharynx, 316 of the oesophagus, 723 of the stomach, 828 of the colon, 498 of the rectum, 320 of the liver, 58 of the gall bladder, 362 of the pancreas, 242 of the larynx, 3,415 of the breast, 726 of the endometrium, 971 of the ovary, 125 of the prostate, 431 of the bladder, 187 of the kidney, 208 of the thyroid, 80 Hodgkin's lymphomas, 200 non-Hodgkin's lymphomas and 120 multiple myelomas. Controls were 7,834 subjects in hospital for acute, non-neoplastic, non-metabolic, non-hormone-related disorders. A history of diabetes was reported by 5.1% of male and 5.4% of female controls. Significantly elevated relative risks (RRs) among subjects with diabetes were observed for cancers of the liver [RR = 2.8, 95% confidence interval (CI) 2.0-3.9], pancreas (RR = 2.1, 95% CI 1.5-2.9) and endometrium (RR 3.4, 95% CI 2.7-4.3). After allowance for obesity and education as well as age and sex, the RRs were 3.0 for liver, 2.3 for pancreas, and 2.8 for endometrium. Diabetic subjects had no elevated risk for any of the other cancer sites considered. For liver and endometrial cancer the RRs remained elevated up to 10 years after diagnosis of diabetes (RR 2.6 and 2.0 respectively), while the RR for pancreatic cancer declined from 3.2 in the first 5 years after diagnosis of diabetes to 2.3 from 5 to 9 years and to 1.3 (95% CI 0.7-2.3) 10 or more years since diagnosis. This suggests that the relationship between diabetes mellitus and liver and endometrial cancer is probably real, while that with pancreatic cancer is compatible with diabetes being an early symptom of the disease, or at least of preneoplastic lesions.

Full text

PDF
950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong B., Lea A. J., Adelstein A. M., Donovan J. W., White G. C., Ruttle S. Cancer mortality and saccharin consumption in diabetics. Br J Prev Soc Med. 1976 Sep;30(3):151–157. doi: 10.1136/jech.30.3.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cuzick J., Babiker A. G. Pancreatic cancer, alcohol, diabetes mellitus and gall-bladder disease. Int J Cancer. 1989 Mar 15;43(3):415–421. doi: 10.1002/ijc.2910430312. [DOI] [PubMed] [Google Scholar]
  3. Franceschi S., la Vecchia C., Negri E., Parazzini F., Boyle P. Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer. 1990;26(7):781–785. doi: 10.1016/0277-5379(90)90151-i. [DOI] [PubMed] [Google Scholar]
  4. Green A., Hougaard P. Epidemiological studies of diabetes mellitus in Denmark: 5. Mortality and causes of death among insulin-treated diabetic patients. Diabetologia. 1984 Mar;26(3):190–194. doi: 10.1007/BF00252405. [DOI] [PubMed] [Google Scholar]
  5. Kelly J. P., Rosenberg L., Kaufman D. W., Shapiro S. Reliability of personal interview data in a hospital-based case-control study. Am J Epidemiol. 1990 Jan;131(1):79–90. doi: 10.1093/oxfordjournals.aje.a115488. [DOI] [PubMed] [Google Scholar]
  6. Kessler I. I. Cancer and diabetes mellitus. A review of the literature. J Chronic Dis. 1971 Jan;23(8):579–600. doi: 10.1016/0021-9681(71)90133-0. [DOI] [PubMed] [Google Scholar]
  7. Kessler I. I. Cancer mortality among diabetics. J Natl Cancer Inst. 1970 Mar;44(3):673–686. [PubMed] [Google Scholar]
  8. La Vecchia C., D'Avanzo B., Negri E., Franceschi S. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991;27(5):582–586. doi: 10.1016/0277-5379(91)90223-z. [DOI] [PubMed] [Google Scholar]
  9. La Vecchia C., Negri E., D'Avanzo B., Boyle P., Franceschi S. Medical history and primary liver cancer. Cancer Res. 1990 Oct 1;50(19):6274–6277. [PubMed] [Google Scholar]
  10. Lawson D. H., Gray J. M., McKillop C., Clarke J., Lee F. D., Patrick R. S. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med. 1986 Oct;61(234):945–955. [PubMed] [Google Scholar]
  11. Levi F., Franceschi S., Negri E., La Vecchia C. Dietary factors and the risk of endometrial cancer. Cancer. 1993 Jun 1;71(11):3575–3581. doi: 10.1002/1097-0142(19930601)71:11<3575::aid-cncr2820711119>3.0.co;2-0. [DOI] [PubMed] [Google Scholar]
  12. Levine W., Dyer A. R., Shekelle R. B., Schoenberger J. A., Stamler J. Post-load plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol. 1990 Feb;131(2):254–262. doi: 10.1093/oxfordjournals.aje.a115495. [DOI] [PubMed] [Google Scholar]
  13. Moss S. E., Klein R., Klein B. E. Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991 Sep;81(9):1158–1162. doi: 10.2105/ajph.81.9.1158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Negri E., La Vecchia C., Franceschi S., D'Avanzo B., Parazzini F. Vegetable and fruit consumption and cancer risk. Int J Cancer. 1991 May 30;48(3):350–354. doi: 10.1002/ijc.2910480307. [DOI] [PubMed] [Google Scholar]
  15. Nyholm H., Djursing H., Hagen C., Agner T., Bennett P., Svenstrup B. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab. 1989 Nov;69(5):946–949. doi: 10.1210/jcem-69-5-946. [DOI] [PubMed] [Google Scholar]
  16. O'Mara B. A., Byers T., Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis. 1985;38(5):435–441. doi: 10.1016/0021-9681(85)90139-0. [DOI] [PubMed] [Google Scholar]
  17. Parazzini F., La Vecchia C., Bocciolone L., Franceschi S. The epidemiology of endometrial cancer. Gynecol Oncol. 1991 Apr;41(1):1–16. doi: 10.1016/0090-8258(91)90246-2. [DOI] [PubMed] [Google Scholar]
  18. Parazzini F., Negri E., La Vecchia C., Bruzzi P., Decarli A. Population attributable risk for endometrial cancer in northern Italy. Eur J Cancer Clin Oncol. 1989 Oct;25(10):1451–1456. doi: 10.1016/0277-5379(89)90103-x. [DOI] [PubMed] [Google Scholar]
  19. Ragozzino M., Melton L. J., 3rd, Chu C. P., Palumbo P. J. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35(1):13–19. doi: 10.1016/0021-9681(82)90025-x. [DOI] [PubMed] [Google Scholar]
  20. Siiteri P. K. Steroid hormones and endometrial cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4360–4366. [PubMed] [Google Scholar]
  21. Smith G. D., Egger M., Shipley M. J., Marmot M. G. Post-challenge glucose concentration, impaired glucose tolerance, diabetes, and cancer mortality in men. Am J Epidemiol. 1992 Nov 1;136(9):1110–1114. doi: 10.1093/oxfordjournals.aje.a116576. [DOI] [PubMed] [Google Scholar]
  22. Whittemore A. S., Paffenbarger R. S., Jr, Anderson K., Halpern J. Early precursors of pancreatic cancer in college men. J Chronic Dis. 1983;36(3):251–256. doi: 10.1016/0021-9681(83)90059-0. [DOI] [PubMed] [Google Scholar]
  23. Wynder E. L., Mabuchi K., Maruchi N., Fortner J. G. Epidemiology of cancer of the pancreas. J Natl Cancer Inst. 1973 Mar;50(3):645–667. doi: 10.1093/jnci/50.3.645. [DOI] [PubMed] [Google Scholar]
  24. Yu M. C., Tong M. J., Govindarajan S., Henderson B. E. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991 Dec 18;83(24):1820–1826. doi: 10.1093/jnci/83.24.1820. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES